Dendritic Cell Vaccination in Pediatric Gliomas: Lessons Learnt and Future Perspectives

Immunotherapy of malignant gliomas with autologous dendritic cells (DCs) in addition to surgery and radiochemotherapy has been a focus of intense research during the past decade. Since both children and adults are affected by this highly aggressive brain tumor, 10–15% of the several hundred vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyrich, Matthias, Rachor, Johannes, Schreiber, Susanne C., Wölfl, Matthias, Schlegel, Paul G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860891/
https://www.ncbi.nlm.nih.gov/pubmed/24400258
http://dx.doi.org/10.3389/fped.2013.00012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860891/
https://www.ncbi.nlm.nih.gov/pubmed/24400258
http://dx.doi.org/10.3389/fped.2013.00012

Ejemplares similares